Wet Age Related Macular Degeneration Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Wet Age Related Macular Degeneration stocks.

Wet Age Related Macular Degeneration Stocks Recent News

Date Stock Title
Nov 21 OMER Omeros Corporation Provides Update on Progress Toward BLA Resubmission
Nov 20 ADVM Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 18 ADVM Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients
Nov 18 RGNX Regenxbio surges 10% as it launches pivotal phase of muscular dystrophy asset trial
Nov 18 ADVM Adverum Reports Positive Ixo-vec Data for Wet Age-Related Macular Degeneration; Shares Rise Pre-Bell
Nov 18 RGNX REGENXBIO INITIATES PIVOTAL PHASE OF AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY AND REPORTS POSITIVE FUNCTIONAL DATA
Nov 18 ADVM Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
Nov 18 RGNX FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
Nov 17 OMER Omeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity Concerns
Nov 15 ADVM Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
Nov 15 RGNX Regenxbio down 13% ahead of data readout for muscular dystrophy asset
Nov 15 CLSD All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
Nov 15 KOD Kodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade)
Nov 15 KOD Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
Nov 15 CLSD Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
Nov 14 KOD Kodiak Sciences GAAP EPS of -$0.84 beats by $0.07
Nov 14 BNTC Benitec GAAP EPS of -$0.48
Nov 14 BNTC Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
Nov 14 KOD Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Wet Age Related Macular Degeneration

Wet Age Related Macular Degeneration (AMD) is a condition that affects the macula, the part of the eye responsible for central vision. It is caused by abnormal blood vessels that grow underneath the macula and leak fluid or blood, causing damage to the macula and leading to vision loss. Wet AMD is the more severe form of AMD and can cause vision loss more quickly than the dry form. Treatment for wet AMD includes injections of medications into the eye, laser treatments, and photodynamic therapy.

Browse All Tags